Genpact (G) — FMR LLC holds 6.1% (10.405M shares) as of 06/30/2026

Rhea-AI Filing Summary

FMR LLC filed an amendment to Schedule 13G/A reporting beneficial ownership of 10,405,025.34 shares of Genpact Ltd. (CUSIP G3922B107), representing 6.1% of the class as of 06/30/2026. The filing states sole dispositive power for 10,405,025.34 shares and sole voting power reported on the cover page. The filing is submitted on behalf of FMR LLC and references Abigail P. Johnson in the cover-page data; signatures are provided under a power of attorney dated 04/13/2026. Exhibit 99 and Exhibit 24 are referenced for subsidiary/authority details.

Insights

Institutional Ownership Analyst

FMR LLC holds a meaningful passive stake in Genpact as of 06/30/2026.

FMR LLC reports beneficial ownership of 10,405,025.34 shares or 6.1% of Genpact's common stock as of 06/30/2026. The filing lists dispositive and voting powers in the cover responses and attaches exhibits for subsidiary/authority details.

The stake size is large enough to warrant attention for ownership disclosure but the amendment does not state any change-of-control intent or transaction plans; cash-flow treatment and intent are not described in the provided excerpt. Subsequent filings or exhibits may specify allocation among funds or voting arrangements.

Securities Compliance Counsel

Amendment documents ownership and delegates signature authority via power of attorney.

The Schedule 13G/A cites a Power of Attorney effective 04/13/2026 (referenced Exhibit 24) and attaches Exhibit 99 for a 13d-1(k)(1) agreement. Signatures by a duly authorized representative appear dated 07/07/2026.

For regulatory clarity, review Exhibit 99 and the referenced Exhibit 24 to confirm which subsidiaries or accounts are covered and whether any holder claims dispositive or voting authority on behalf of others as described under Item 6.

Key Figures

Filing type: Schedule 13G/A (Amendment No. 8) Beneficial ownership: 10,405,025.34 shares Percent of class: 6.1% +3 more

6 metrics

Filing type Schedule 13G/A (Amendment No. 8) cover data

Beneficial ownership 10,405,025.34 shares as of 06/30/2026

Percent of class 6.1% as of 06/30/2026

CUSIP G3922B107 Genpact Ltd common stock

Power of Attorney date 04/13/2026 authority referenced for signatures

Signature date 07/07/2026 signature by Richard Bourgelas on behalf of FMR LLC

Key Terms

Beneficial ownership, Schedule 13G/A, Power of Attorney

3 terms

Beneficial ownership regulatory

"Item 4. Amount beneficially owned: 10405025.34"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Schedule 13G/A regulatory

"CONTENT METADATA: form_type: SCHEDULE 13G/A"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Power of Attorney legal

"Duly authorized under Power of Attorney effective as of April 13, 2026"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/08/2026 - 10:12 AM Accepted by SEC EDGAR 07/08/2026 - 10:11 AM Learn about SEC filing dates

FAQ

What stake does FMR LLC report in Genpact (G)?

FMR LLC reports beneficial ownership of 10,405,025.34 shares, equal to 6.1% of Genpact's common stock as of 06/30/2026. The filing shows sole dispositive power for 10,405,025.34 shares and references exhibits for subsidiary and authority details.

Does the Schedule 13G/A indicate FMR LLC will sell or buy more Genpact shares?

The amendment does not state any buy or sell plans. It documents current beneficial ownership and voting/dispositive powers as of 06/30/2026 and references exhibits for authority; no transaction intent or proceeds treatment is described in the excerpt.

Who signed the Schedule 13G/A for FMR LLC?

Richard Bourgelas signed as a duly authorized representative on behalf of FMR LLC and on behalf of Abigail P. Johnson under a Power of Attorney effective 04/13/2026, with signature dates shown as 07/07/2026 in the filing excerpt.

What exhibits accompany this amendment and why do they matter?

The filing references Exhibit 99 and Exhibit 24 (the Power of Attorney). These exhibits identify subsidiary classification and authority details that explain which entities/accounts the reported holdings represent and who may direct voting or dispositions.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 8)

GENPACT LTD

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

G3922B107

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G3922B107

1

Names of Reporting Persons

FMR LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 10,174,053.02
6	Shared Voting Power 0.00
7	Sole Dispositive Power 10,405,025.34
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,405,025.34

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.1 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP Number(s): G3922B107

1

Names of Reporting Persons

Abigail P. Johnson

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 10,405,025.34
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,405,025.34

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.1 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GENPACT LTD
(b)	Address of issuer's principal executive offices: CANON'S COURT,22 VICTORIA STREET,HAMILTON,D0,HM 12
Item 2.
(a)	Name of person filing: FMR LLC
(b)	Address or principal business office or, if none, residence: 245 Summer Street, Boston, Massachusetts 02210
(c)	Citizenship: Not applicable
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: G3922B107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 10405025.34
(b)	Percent of class: 6.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page.
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 10405025.34
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of GENPACT LTD. No one other person's interest in the COMMON STOCK of GENPACT LTD is more than five percent of the total outstanding COMMON STOCK.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See attached Exhibit 99.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

FMR LLC

Signature:	Richard Bourgelas
Name/Title:	Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:	07/07/2026

Abigail P. Johnson

Signature:	Richard Bourgelas
Name/Title:	Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of Abigail P. Johnson*
Date:	07/07/2026

Comments accompanying signature: *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on April 29,2026, accession number: 0000315066-26-000738.

Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.